CD-functionalized chitosan hydrogels for pH-responsive drug delivery
Traditional chitosan hydrogels are highly biocompatible but too hydrophilic to effectively load and sustain release of hydrophobic drugs. In a
Tag: sustained release
Doxycycline release from cyclodextrin oligomer-containing collagen gels
Researchers at Case Western Reserve University incorporated γ-cyclodextrin oligomers into native collagen gels during fibril formation and studied loading/release of
Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
Drug delivery using dissolving or biodegradable polymer microneedles has garnered significant interest in drug administration because of their biocompatibility, fast
Targeted Codelivery of Doxorubicin and Carvacrol Nanogels
In this study, nanogels were developed using thiolated hyaluronic acid (HASH) and vinyl sulfonated β-cyclodextrin (CDVS) via a water-in-oil emulsion
Cyclodextrin metal-organic frameworks on ethylene adsorption and release behaviors and their ripening studies on kiwifruit
thylene plays a pivotal role in both chemical and agricultural sectors, yet its use is limited by stringent storage requirements
Mucoadhesive hydrogel film based on cyclodextrin cross-linked with thiolated hydroxyethyl cellulose for mucosal delivery of cisplatin
The efficacy of cisplatin (CTN) is limited due to its short half-life and toxic side effects. This study aimed to
Hydrogel containing oxidized beta-cyclodextrin for in-vivo release of a medication: a sheep model
Cyclodextrins are seldom used in sustained-release formulations, as they are more commonly associated with rapid drug delivery. However, cyclodextrin complexes
Fabrication of biocompatible water-soluble supramolecular nanofibers of oseltamivir with methyl-β-cyclodextrin for enhanced drug release
This research aims to create the nanofibers (NF) which involves incorporating an antiviral agent, oseltamivir (OTV) into the CD cavity,
Drug-like properties of tyrosine kinase inhibitors in ophthalmology: Formulation and topical availability
Tyrosine kinase inhibitors (TKIs) can inhibit edema and neovascularization, such as in age-related macular degeneration and diabetic retinopathy. However, their
Shear-thinning hydrogel for allograft cell transplantation and externally controlled transgene expression
This work establishes the design of a fully synthetic, shear-thinning hydrogel platform that is injectable and can isolate engineered, allogeneic